Every child responds differently to growth hormone therapy, but results tend to follow predictable patterns. This timeline helps parents understand what milestones to expect — month by month and year by year — so you know what's normal, what's exceptional, and when to ask questions.
The earliest weeks of growth hormone therapy are about your child's body adapting to treatment. Visible height changes are unlikely during this phase — and that is completely normal. Don't be discouraged.
What you may notice during the first three months:
Many parents feel anxious when they don't see immediate height changes. This is the most common reason families worry unnecessarily early in treatment. The medication is working — growth at the cellular and hormonal level precedes visible changes. Trust the process and keep up with daily injections consistently.
This is when most families see the first tangible evidence that therapy is working. The changes are subtle at first but clearly measurable:
The second half of the first year is typically when growth hormone therapy produces its most visible results. This is the period that convinces most families that treatment was the right decision:
Many children with growth hormone deficiency grow only 1 to 2 inches per year — falling further behind peers with each passing year. Growth charts show a flat or declining trajectory.
With consistent treatment, first-year growth of 3 to 5 inches is typical. Growth charts show a clear upward shift — the child is catching up to their genetic potential.
The second year of treatment typically shows continued above-average growth, though the rate may moderate slightly from the dramatic Year 1 peak:
Growth hormone therapy is a long-term commitment. For many children, treatment continues for several years to maximize height potential:
Not every child responds identically to growth hormone therapy. The following factors have the greatest influence on treatment outcomes:
Younger children generally respond more robustly. Starting earlier preserves more growth potential and allows more years of therapy before growth plates close.
Children with confirmed growth hormone deficiency (GHD) typically respond more dramatically than those with idiopathic short stature (ISS), though both groups benefit from treatment.
Consistency with daily injections is one of the most critical factors. Missing doses significantly reduces treatment effectiveness. Daily compliance is essential.
Parental height sets the ceiling for a child's growth potential. Growth hormone therapy helps a child reach their genetic potential — it does not exceed it.
The right dose matters. Too low and growth is suboptimal; dosing is carefully adjusted based on lab results, weight, and growth response over time.
Open growth plates are required for treatment to work. Bone age X-rays confirm whether growth potential remains. Once plates close, no medication can add height.
The younger treatment begins, the better. Once growth plates close — which happens permanently in the mid-to-late teenage years — no medication can add inches. Every month of delay reduces potential height gain. If your child is growing slowly, the time to act is now, not next year. Early evaluation always preserves the most options.
The following visual shows how growth velocity typically changes across each phase of treatment. The wider the bar, the greater the relative growth rate during that period:
Most families notice the first measurable height increase between months 3 and 6 of treatment. Before that, you may observe improvements in energy, sleep quality, and body composition. The most dramatic growth typically occurs during the first 12 months, with many children gaining 3 to 5 inches in year one compared to 1 to 2 inches pre-treatment.
Total height gain depends on several factors including age at treatment start, diagnosis, adherence, genetics, and how much growth potential remains (growth plate status). Children with growth hormone deficiency who begin treatment early often gain significantly more than their projected adult height without treatment. First-year gains of 3 to 5 inches are common, with continued above-average growth in subsequent years.
If growth velocity is below expectations after 6 to 12 months, the physician will review several factors: adherence to the daily injection schedule, current dosing, lab results including IGF-1 levels, and whether the original diagnosis needs reassessment. Dose adjustments are common and often improve response. Consistent daily administration is one of the most important factors in treatment success.
Treatment duration varies but typically continues for several years — often until the child reaches near-adult height or until growth plates close. Some children are treated for 3 to 5 years, while others may continue longer. The physician monitors bone age regularly to assess remaining growth potential and determines the appropriate stopping point on an individual basis.
Our care team reviews your child's growth history and helps you understand whether a specialist evaluation may be right for your family. No cost. No obligation. Available nationwide via telemedicine.
Medical Disclaimer: HGHKids.com is a privately operated educational and referral platform. We do not diagnose, treat, or prescribe. All medical decisions are made by licensed physicians following appropriate evaluation. Information on this site is for educational purposes only and does not constitute medical advice.